Epidemiology and demographics template
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Charmaine Patel, M.D. [2]
Introduction
Overview
(insert disease state here) is a major health problem affecting _____ patients in the United States and ____ patients worldwide.
or
(insert disease state here) is a common health problem affecting _____ patients in the United States and ____ patients worldwide.
or
(insert disease state here) is a common health problem that tends to more often affect the ____ (elderly for example) and _____ (men for example).
or
(insert disease state here) is a rare disease (defined as a prevalence of < 50 per 100,000 patients or < 200,000 patients affected in the United States) with a prevalence of ______ per 100,000 patients.
Prevalence
Worldwide, the prevalence of (insert disease state here) ranges from a low of _____ per 100,000 patients, to a high of _____ per 100,000 patients with an average prevalence of _____ per 100,000 patients.
Worldwide, the prevalence of (insert disease state here) is _____ per 100,000 patients.
In developed countries, the prevalence of (insert disease state here) ranges from a low of _____ per 100,000 patients, to a high of _____ per 100,000 patients with an average prevalence of _____ per 100,000 patients.
In developed countries, the prevalence of (insert disease state here) is _____ per 100,000 patients.
In developing countries, the prevalence of (insert disease state here) ranges from a low of _____ per 100,000 patients, to a high of _____ per 100,000 patients with an average prevalence of _____ per 100,000 patients.
In developing countries, the prevalence of (insert disease state here) is _____ per 100,000 patients.
In Africa, the prevalence of (insert disease state here) ranges from a low of _____ per 100,000 patients, to a high of _____ per 100,000 patients with an average prevalence of _____ per 100,000 patients.
In Africa, the prevalence of (insert disease state here) is _____ per 100,000 patients.
Incidence
Worldwide, the incidence of (insert disease state here) ranges from a low of _____ per 100,000 patients, to a high of _____ per 100,000 patients with an average incidence of _____ per 100,000 patients.
Worldwide, the incidence of (insert disease state here) is _____ per 100,000 patients.
In developed countries, the incidence of (insert disease state here) ranges from a low of _____ per 100,000 patients, to a high of _____ per 100,000 patients with an average incidence of _____ per 100,000 patients.
In developed countries, the incidence of (insert disease state here) is _____ per 100,000 patients.
In developing countries, the incidence of (insert disease state here) ranges from a low of _____ per 100,000 patients, to a high of _____ per 100,000 patients with an average incidence of _____ per 100,000 patients.
In developing countries, the incidence of (insert disease state here) is _____ per 100,000 patients.
In Africa, the incidence of (insert disease state here) ranges from a low of _____ per 100,000 patients, to a high of _____ per 100,000 patients with an average incidence of _____ per 100,000 patients.
In Africa, the incidence of (insert disease state here) is _____ per 100,000 patients.
Age
The prevalence of (insert disease state here) increases with age.
Gender
(insert disease state here) is more common in males females. The prevalence of (insert disease state here) among men is ____ per 100,000, while it is _____ per 100,000 among women. The incidence of (insert disease state here) among men is ____ per 100,000, while it is _____ per 100,000 among women.
or
Gender is not associated with an increased risk of (insert disease state here)
Race
Race is not associated with an increased risk of (insert disease state here)